Literature DB >> 19879850

Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.

Wanna Chaijaroenkul1, Raewadee Wisedpanichkij, Kesara Na-Bangchang.   

Abstract

Malaria is one of the major causes of morbidity and mortality worldwide. The major factor which has aggravated the situation is the emergence of multidrug resistant Plasmodium falciparum malaria. To successfully deal with the problem, thorough understanding of the molecular bases for reduced parasite sensitivity to existing antimalarial drugs is of considerable importance. The objective of this work was to broaden the insight into the molecular mechanisms of resistance of P. falciparum to quinoline-containing antimalarials and artemisinin derivatives. Polymorphisms of the candidate genes pfmdr1 and pfcrt were investigated in relation to the susceptibility (in vitro sensitivity) of P. falciparum isolates to chloroquine (CQ), mefloquine (MQ), quinine (QN) and the artemisinin derivative - artesunate (AS). A total of 26 P. falciparum isolates were successful cultured. In vitro sensitivity results indicate the increase in susceptibility of P. falciparum strains in Thailand to CQ, while the susceptibility to MQ and QN was markedly declined. The pattern of cross-resistance was observed between MQ vs QN vs AS. Only one point mutation in the pfmdr1 gene, i.e., N86Y was observed with low prevalence of 7.7% (2/26). In contrast, the mutations at positions 76T, 220S, 271E, 326S, 356T and 371I in the pfcrt gene were identified in almost all isolates (25 isolates, 96.2%). The association between polymorphisms of the pfmdr1 and susceptibility of the parasite to MQ and QN was observed (increased susceptibilities to MQ and QN in isolates with mutations). Moreover, the correlation between pfmdr1 gene amplification and susceptibility of the parasite to MQ, QN and AS was observed (decreased susceptibilities to MQ, QN and AS in isolates with increased pfmdr1 copy number). Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19879850     DOI: 10.1016/j.actatropica.2009.10.016

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  21 in total

1.  Discordant temporal evolution of Pfcrt and Pfmdr1 genotypes and Plasmodium falciparum in vitro drug susceptibility to 4-aminoquinolines after drug policy change in French Guiana.

Authors:  Eric Legrand; Joséphine Yrinesi; Marie-Thérèse Ekala; Julie Péneau; Béatrice Volney; Franck Berger; Christiane Bouchier; Stéphane Bertani; Lise Musset; Jean-Baptiste Meynard; Odile Mercereau-Puijalon
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

Review 2.  Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.

Authors:  Robert L Summers; Megan N Nash; Rowena E Martin
Journal:  Cell Mol Life Sci       Date:  2012-06       Impact factor: 9.261

3.  Antimalarial drug sensitivity profile of western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay and molecular analysis.

Authors:  Hoseah M Akala; Fredrick L Eyase; Agnes C Cheruiyot; Angela A Omondi; Bernhards R Ogutu; Norman C Waters; Jacob D Johnson; Mark E Polhemus; David C Schnabel; Douglas S Walsh
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

4.  In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from Kenya.

Authors:  John Okombo; Steven M Kiara; Josea Rono; Leah Mwai; Lewa Pole; Eric Ohuma; Steffen Borrmann; Lynette Isabella Ochola; Alexis Nzila
Journal:  Antimicrob Agents Chemother       Date:  2010-06-01       Impact factor: 5.191

5.  Polymorphisms of molecular markers of antimalarial drug resistance and relationship with artesunate-mefloquine combination therapy in patients with uncomplicated Plasmodium falciparum malaria in Thailand.

Authors:  Poonuch Muhamad; Papichaya Phompradit; Wannapa Sornjai; Thunyaluk Maensathian; Wanna Chaijaroenkul; Ronnatrai Rueangweerayut; Kesara Na-Bangchang
Journal:  Am J Trop Med Hyg       Date:  2011-09       Impact factor: 2.345

6.  Polymorphic patterns of pfcrt and pfmdr1 in Plasmodium falciparum isolates along the Thai-Myanmar border.

Authors:  Phunuch Muhamad; Wanna Chaijaroenkul; Papichaya Phompradit; Ronnatrai Rueangweerayut; Pongsri Tippawangkosol; Kesara Na-Bangchang
Journal:  Asian Pac J Trop Biomed       Date:  2013-12

7.  In vitro sensitivities of Plasmodium falciparum isolates from the China-Myanmar border to piperaquine and association with polymorphisms in candidate genes.

Authors:  Mingming Hao; Dandan Jia; Qing Li; Yongshu He; Lili Yuan; Shuhui Xu; Kexuan Chen; Jia Wu; Lijuan Shen; Lin Sun; Hongbin Zhao; Zhaoqing Yang; Liwang Cui
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

8.  Structure-based approach to the identification of a novel group of selective glucosamine analogue inhibitors of Trypanosoma cruzi glucokinase.

Authors:  Edward L D'Antonio; Mason S Deinema; Sean P Kearns; Tyler A Frey; Scott Tanghe; Kay Perry; Timothy A Roy; Hanna S Gracz; Ana Rodriguez; Jennifer D'Antonio
Journal:  Mol Biochem Parasitol       Date:  2016-01-14       Impact factor: 1.759

9.  Double mutation in the pfmdr1 gene is associated with emergence of chloroquine-resistant Plasmodium falciparum malaria in Eastern India.

Authors:  Sabyasachi Das; Santanu Kar Mahapatra; Satyajit Tripathy; Sourav Chattopadhyay; Sandeep Kumar Dash; Debasis Mandal; Balaram Das; Amiya Kumar Hati; Somenath Roy
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191

10.  Ex vivo drug sensitivity profiles of Plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidine-rich protein-2 assay.

Authors:  Stuart D Tyner; Chanthap Lon; Youry Se; Delia Bethell; Doung Socheat; Harald Noedl; Darapiseth Sea; Wichai Satimai; Kurt Schaecher; Wiriya Rutvisuttinunt; Mark M Fukuda; Suwanna Chaorattanakawee; Kritsanai Yingyuen; Siratchana Sundrakes; Panjaporn Chaichana; Piyaporn Saingam; Nillawan Buathong; Sabaithip Sriwichai; Soklyda Chann; Ans Timmermans; David L Saunders; Douglas S Walsh
Journal:  Malar J       Date:  2012-06-13       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.